# IDEXX Laboratories (IDXX) — Earnings

IDXX · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/idxx/earnings

## Most recent quarter

| Metric | Value |
| --- | --- |
| Fiscal period | Q2 2026 |
| Period end | Jun 30, 2026 |
| EPS actual | $4.27 |
| EPS estimate | $3.94 |
| EPS surprise | +8.28% |
| Revenue surprise | +1.36% |
| Revenue | $1.2B |
| Revenue estimate | $1.2B |
| Reported | Aug 4, 2026 |
| SEC filing | [View filing](https://www.sec.gov:443/Archives/edgar/data/874716/000087471626000123/idxx-20260630.htm) |
| Earnings call | [Transcript](http://o.thsi.cn/dc-d-stock-america.teleconference/40ee294c-54aa-b302-51c3-a072eee7daf1.html) |

IDEXX Laboratories reported Q2 2026 results on August 4, 2026. Earnings per share came in at $4.27, ahead of the $3.94 estimate by 8.28%. Revenue was $1.2 billion, 1.36% above the consensus. Compared with Q2 2025, EPS rose about 18% from $3.63, and revenue grew from $1.1 billion. Both figures were the highest in the table.

The longer record shows steady growth. Annual EPS rose every year, from $8.03 in 2022 to $10.07 in 2023, $10.67 in 2024 and $13.07 in 2025, about 63% over three years. The first half of 2026 adds up to $7.74, about 17% more than the same period a year earlier. Quarterly revenue has climbed from $801.1 million in Q4 2021, the low in the table. Over the last 20 quarters, IDEXX beat the EPS estimate 18 times. The two misses were Q2 2022, at 0.13% below, and Q2 2024, at 15.41% below. The latest eight quarters were all beats.

IDEXX reported Q3 between October 31 and November 3 in each of the past five years. That points to the turn of October and November 2026 for the next report. It will be compared with Q3 2025's $3.40 per share.

## Earnings history

| Fiscal period | Report date | EPS estimate | EPS actual | Surprise | Revenue estimate | Revenue actual |
| --- | --- | --- | --- | --- | --- | --- |
| Q2 2026 | Aug 4, 2026 | $3.94 | $4.27 | 8.28% | $1.2B | $1.2B |
| Q1 2026 | May 5, 2026 | $3.41 | $3.47 | 1.74% | $1.1B | $1.1B |
| Q4 2025 | Feb 2, 2026 | $2.93 | $3.08 | 5.00% | $1.1B | $1.1B |
| Q3 2025 | Nov 3, 2025 | $3.14 | $3.40 | 8.35% | $1.1B | $1.1B |
| Q2 2025 | Aug 4, 2025 | $3.30 | $3.63 | 9.93% | $1.1B | $1.1B |
| Q1 2025 | May 1, 2025 | $2.85 | $2.96 | 3.93% | $997.1M | $998.4M |
| Q4 2024 | Feb 3, 2025 | $2.40 | $2.62 | 9.04% | $935.1M | $954.3M |
| Q3 2024 | Oct 31, 2024 | $2.68 | $2.80 | 4.46% | $980.3M | $975.5M |
| Q2 2024 | Aug 6, 2024 | $2.88 | $2.44 | -15.41% | $1.0B | $1.0B |
| Q1 2024 | May 1, 2024 | $2.71 | $2.81 | 3.60% | $964.4M | $964.1M |
| Q4 2023 | Feb 5, 2024 | $2.12 | $2.32 | 9.22% | $891.9M | $901.6M |
| Q3 2023 | Nov 1, 2023 | $2.37 | $2.53 | 6.72% | $926.9M | $915.5M |
| Q2 2023 | Aug 1, 2023 | $2.47 | $2.67 | 7.90% | $934.6M | $943.6M |
| Q1 2023 | May 2, 2023 | $2.42 | $2.55 | 5.30% | $890.7M | $900.2M |
| Q4 2022 | Feb 6, 2023 | $1.92 | $2.05 | 6.57% | $820.9M | $828.6M |
| Q3 2022 | Nov 1, 2022 | $2.05 | $2.15 | 4.87% | $830.0M | $841.7M |
| Q2 2022 | Aug 2, 2022 | $1.56 | $1.56 | -0.13% | $863.1M | $860.5M |
| Q1 2022 | May 4, 2022 | $2.25 | $2.27 | 0.99% | $837.1M | $836.5M |
| Q4 2021 | Feb 2, 2022 | $1.72 | $1.89 | 9.99% | $781.8M | $801.1M |
| Q3 2021 | Nov 2, 2021 | $1.91 | $2.03 | 6.02% | $797.6M | $810.4M |

## Frequently Asked Questions

### When did IDEXX Laboratories (IDXX) last report earnings?

IDEXX Laboratories last reported on Aug 4, 2026, covering fiscal Q2 2026.

### Did IDXX beat earnings estimates?

Yes. IDEXX Laboratories reported EPS of $4.27 for Q2 2026 against a $3.94 estimate — a 8.28% beat.

### How much revenue did IDXX report last quarter?

IDEXX Laboratories reported $1.2B in revenue for Q2 2026, against a consensus estimate of $1.2B.

## Similar Stocks

- [NVST](https://www.lighthorse.io/tickers/nvst) — Envista Holdings Corporation Common Stock

---

Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).